Welcome to LookChem.com Sign In|Join Free

CAS

  • or

301232-45-1

Post Buying Request

301232-45-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

301232-45-1 Usage

General Description

Tert-butyl 4-(3-ethoxy-3-oxopropyl)piperidine-1-carboxylate is a chemical compound. As the name suggests, it includes elements such as tert-butyl and ethoxy groups, along with a piperidine ring and a carboxylate ester functional group. tert-butyl 4-(3-ethoxy-3-oxopropyl)piperidine-1-carboxylate falls under the category of organic compounds, specifically, tertiary butyl groups are a subset of alkyl compounds. Its exact properties such as reactivity, stability, toxicology or applications may vary based on its specific interactions with other compounds, and are not generally described unless in a specific context or study.

Check Digit Verification of cas no

The CAS Registry Mumber 301232-45-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,1,2,3 and 2 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 301232-45:
(8*3)+(7*0)+(6*1)+(5*2)+(4*3)+(3*2)+(2*4)+(1*5)=71
71 % 10 = 1
So 301232-45-1 is a valid CAS Registry Number.

301232-45-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 4-(3-ethoxy-3-oxopropyl)piperidine-1-carboxylate

1.2 Other means of identification

Product number -
Other names Tert-Butyl 4-(3-Ethoxy-3-Oxopropyl)Piperidine-1-Carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:301232-45-1 SDS

301232-45-1Relevant articles and documents

Electrochemical Tandem Olefination and Hydrogenation Reaction with Ammonia

Zhang, Xiaofeng,Jiang, Runze,Cheng, Xu

, p. 16016 - 16025 (2021/08/24)

An electrochemical Horner-Wadsworth-Emmons/hydrogenation tandem reaction was achieved using ammonia as electron and proton donors. The reaction could give two-carbon-elongated ester and nitrile from aldehyde or ketones directly. This reaction could proceed with a catalytic amount of base or even without a base. The ammonia provides both the electron and proton for this tandem reaction and enables the catalyst-free hydrogenation of an α,β-unsaturated HWE intermediate. More than 40 examples were reported, and functional groups, including heterocycles and hydroxyl, were tolerated.

One-Pot, Tandem Wittig Hydrogenation: Formal C(sp3)-C(sp3) Bond Formation with Extensive Scope

Devlin, Rory,Jones, David J.,Mcglacken, Gerard P.

supporting information, p. 5223 - 5228 (2020/07/14)

A one-pot, tandem Wittig hydrogenation of aldehydes with stabilized ylides is reported, representing a formal C(sp3)-C(sp3) bond construction. The tandem reaction operates under mild conditions, is high yielding, and is broad in scope. Chemoselectivity for olefin reduction is observed, and the methodology is demonstrated in the synthesis of lapatinib analogues and a formal synthesis of (±)-cuspareine. Early insights suggest that the chemoselectivity observed in the reduction step is due to partial poisoning of the catalyst, after step one, thus adding to the power of the one-pot procedure.

Design, synthesis, and structure-activity relationships of potent GPIIb/IIIa antagonists: Discovery of FK419

Yamanaka, Toshio,Ohkubo, Mitsuru,Kuroda, Satoru,Nakamura, Hideko,Takahashi, Fumie,Aoki, Toshiaki,Mihara, Kayoko,Seki, Jiro,Kato, Masayuki

, p. 4343 - 4352 (2007/10/03)

The discovery of the non-peptide antiplatelet injectable agent FK419 is reported. Based on the β-turn structure of RGD peptide sequences in the α chain of fibrinogen, which binds the glycoprotein IIb/IIIa (GPIIb/IIIa) on the surface of platelets to induce

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 301232-45-1